← Operating Liquidation Value Rankings
Operating Liquidation Value — Pharmaceuticals
Rankings as of 2025-12-31
Last updated: 2026-04-13 03:09 UTC
| Rank | Ticker | Company | Value | Period |
|---|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals, Inc. | $4.72B | 2025-12-31 |
| 2 | VRTX | Vertex Pharmaceuticals Inc | $2.82B | 2025-12-31 |
| 3 | ABT | Abbott Laboratories | $-7.69B | 2025-12-31 |
| 4 | LLY | Eli Lilly and Company | $-38.69B | 2025-12-31 |
| 5 | MRK | Merck & Co., Inc. | $-43.27B | 2025-12-31 |
| 6 | JNJ | Johnson & Johnson | $-43.89B | 2025-12-28 |
| 7 | PFE | Pfizer Inc | $-77.58B | 2025-12-31 |
| 8 | ABBV | Abbvie Inc. | $-85.95B | 2025-12-31 |